4//SEC Filing
Zimmermann Carolyne 4
Accession 0001567619-21-011946
CIK 0001650648other
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 8:28 PM ET
Size
5.7 KB
Accession
0001567619-21-011946
Insider Transaction Report
Form 4
Zimmermann Carolyne
Chief Business Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-06-07+60,000→ 60,000 totalExercise: $26.83Exp: 2031-06-06→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]The stock option will vest with respect to 25% of the total number of the underlying shares on June 7, 2022, and the remaining shares will vest in equal monthly installments over the following three-year period, such that the stock option will be fully vested on June 7, 2025, subject to the Reporting Person continuing to be a service provider to Issuer through each vesting date.
Documents
Issuer
4D Molecular Therapeutics Inc.
CIK 0001650648
Entity typeother
Related Parties
1- filerCIK 0001860163
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 8:28 PM ET
- Size
- 5.7 KB